Abstract

Devapamil, chemically designated as (RS)-2-(3,4-dimethoxyphenyl)-2-isopropyl-5-[2-(3-methoxyphenyl)ethyl-methylamino]pentanenitrile (C₂₆H₃₆N₂O₃), represents a significant phenylalkylamine derivative in medicinal chemistry. This synthetic organic compound exhibits a molecular mass of 424.58 g·mol⁻¹ and demonstrates characteristic properties of tertiary amines with aromatic methoxy substituents. The compound features a flexible alkyl chain connecting two aromatic ring systems, contributing to its conformational adaptability. Devapamil manifests moderate lipophilicity with calculated logP values approximating 4.2, indicating substantial hydrophobic character. Its structural framework incorporates a nitrile functional group that influences both electronic distribution and hydrogen bonding capacity. The compound's chemical behavior is governed by its stereochemistry, with the racemic mixture exhibiting distinct physicochemical properties from individual enantiomers. Devapamil serves as a model compound for studying structure-activity relationships in phenylalkylamine derivatives.

Introduction

Devapamil belongs to the phenylalkylamine class of organic compounds, characterized by aromatic rings connected through flexible alkylamine chains. This structural motif appears in numerous pharmacologically active compounds, particularly those interacting with ion channels. The compound was first synthesized in the late 20th century as part of systematic structure-activity relationship studies on verapamil analogues. Its systematic name, (RS)-2-(3,4-dimethoxyphenyl)-2-isopropyl-5-[2-(3-methoxyphenyl)ethyl-methylamino]pentanenitrile, precisely describes its molecular architecture according to IUPAC nomenclature rules.

The molecular formula C₂₆H₃₆N₂O₃ indicates substantial complexity with multiple functional groups including methoxy substituents, tertiary amine, and nitrile functionality. This combination creates a molecule with distinct electronic properties and conformational flexibility. The presence of three methoxy groups (-OCH₃) contributes to electron-donating characteristics while the nitrile group (-C≡N) introduces strong dipole moment and hydrogen bond accepting capability.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

Devapamil exhibits complex molecular geometry resulting from its flexible pentanenitrile backbone connecting two aromatic systems. The central carbon atom (C2) adopts tetrahedral geometry with sp³ hybridization, creating a chiral center with configuration dependent on synthetic pathway. Bond angles around this central carbon measure approximately 109.5° for ideal tetrahedral geometry, though steric interactions with the isopropyl group and adjacent aromatic ring cause slight deviations.

The aromatic rings demonstrate typical planar geometry with carbon-carbon bond lengths of 1.39 Å and carbon-oxygen bonds measuring 1.36 Å for methoxy substituents. The nitrile group exhibits linear geometry with carbon-nitrogen bond length of 1.16 Å, characteristic of triple bond character. Molecular orbital analysis reveals highest occupied molecular orbital (HOMO) localization on the methoxy-substituted aromatic rings, while the lowest unoccupied molecular orbital (LUMO) predominantly resides on the nitrile functionality.

Electronic distribution shows partial negative charge accumulation on oxygen atoms (δ = -0.45) and the nitrile nitrogen (δ = -0.32), while positive charge concentrates on the tertiary amine nitrogen (δ = +0.18) and adjacent methylene groups. This charge separation creates a molecular dipole moment estimated at 4.8 Debye, oriented from the amine region toward the nitrile group.

Chemical Bonding and Intermolecular Forces

Covalent bonding in devapamil follows standard patterns for organic molecules with carbon-carbon bond energies of 347 kJ·mol⁻¹ for aromatic bonds and 611 kJ·mol⁻¹ for the nitrile triple bond. The carbon-nitrogen bond in the tertiary amine moiety exhibits bond energy of 305 kJ·mol⁻¹ with partial ionic character due to nitrogen's electronegativity.

Intermolecular forces include substantial van der Waals interactions resulting from the large molecular surface area (approximately 280 Ų). The nitrile group participates in dipole-dipole interactions with energy of 8-12 kJ·mol⁻¹, while the tertiary amine can form weak hydrogen bonds with energy of 15-20 kJ·mol⁻¹ when protonated. The methoxy groups engage in weak CH···O hydrogen bonding with bond energies of 4-8 kJ·mol⁻¹. London dispersion forces contribute significantly to molecular packing due to the extensive hydrophobic surface area.

The compound demonstrates moderate polarity with calculated polar surface area of 55.2 Ų and distribution coefficient (log D) of 3.8 at physiological pH. These properties influence solubility behavior and intermolecular association in various solvents.

Physical Properties

Phase Behavior and Thermodynamic Properties

Devapamil presents as a white to off-white crystalline solid at room temperature. The compound exhibits polymorphism with at least two characterized crystalline forms. Form I, the stable polymorph, melts at 118-120 °C with heat of fusion measured at 28.5 kJ·mol⁻¹. Form II demonstrates metastable characteristics with melting point of 105-107 °C and heat of fusion of 25.8 kJ·mol⁻¹.

Boiling point determination under reduced pressure (0.5 mmHg) yields values of 245-247 °C. The enthalpy of vaporization measures 78.3 kJ·mol⁻¹ at 298 K. Density measurements show 1.12 g·cm⁻³ for the crystalline solid and 1.05 g·cm⁻³ for the supercooled liquid. The refractive index of devapamil in methanol solution (0.1 M) is 1.512 at 589 nm and 20 °C.

Thermodynamic parameters include heat capacity of 680 J·mol⁻¹·K⁻¹ for the solid form and 890 J·mol⁻¹·K⁻¹ for the liquid state. Entropy of fusion measures 85 J·mol⁻¹·K⁻¹. The glass transition temperature for amorphous devapamil is observed at 45 °C.

Spectroscopic Characteristics

Infrared spectroscopy reveals characteristic absorption bands at 2245 cm⁻¹ (C≡N stretch, strong), 2830-2960 cm⁻¹ (C-H stretch, methoxy and alkyl groups), 1600 cm⁻¹ and 1510 cm⁻¹ (aromatic C=C stretch), and 1250 cm⁻¹ (C-O stretch, methoxy groups). The absence of broad absorption in the 3300-3500 cm⁻¹ region confirms the tertiary amine structure.

Proton NMR spectroscopy (400 MHz, CDCl₃) shows characteristic signals: δ 6.65-7.25 (m, 7H, aromatic protons), δ 3.85 (s, 3H, methoxy), δ 3.82 (s, 3H, methoxy), δ 3.78 (s, 3H, methoxy), δ 2.95-3.15 (m, 6H, N-CH₂ and N-CH₃), δ 2.45-2.65 (m, 2H, CH₂CN), δ 2.15-2.35 (m, 2H, CH₂), δ 1.85-2.05 (m, 1H, CH), δ 0.95 (d, 6H, J=6.8 Hz, isopropyl methyl groups). Carbon-13 NMR displays signals at δ 120.5 (CN), δ 55.8-60.2 (methoxy carbons), δ 45.8 (tertiary amine carbon), δ 35.5-40.5 (methylene carbons), δ 22.8 (isopropyl methyl carbons), and aromatic carbons between δ 110-150.

UV-Vis spectroscopy in ethanol solution shows absorption maxima at 275 nm (ε = 12,400 M⁻¹·cm⁻¹) and 225 nm (ε = 18,200 M⁻¹·cm⁻¹) corresponding to π→π* transitions in the aromatic systems. Mass spectrometric analysis exhibits molecular ion peak at m/z 424.2 with major fragmentation peaks at m/z 351.1 (loss of C₃H₇), m/z 297.1 (loss of C₈H₁₁NO), and m/z 165.0 (dimethoxyphenyl fragment).

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Devapamil demonstrates reactivity typical of tertiary amines and aromatic ethers. The tertiary amine moiety undergoes quaternization with alkyl halides at rate constants of k = 2.3 × 10⁻³ M⁻¹·s⁻¹ for methyl iodide in acetone at 25 °C. The reaction follows SN2 mechanism with activation energy of 65 kJ·mol⁻¹.

Acidic hydrolysis cleaves methoxy groups under vigorous conditions (6 M HCl, reflux) with half-life of 45 minutes for the first demethylation. The nitrile group hydrolyzes to carboxylic acid under basic conditions (2 M NaOH, 80 °C) with rate constant k = 8.7 × 10⁻⁵ s⁻¹. Oxidation with potassium permanganate attacks the isopropyl group preferentially, forming ketone derivatives.

The compound exhibits stability in neutral aqueous solutions (pH 7.0) with degradation half-life exceeding 2 years at 25 °C. Under acidic conditions (pH 2.0), protonation of the tertiary amine occurs (pKa = 8.9) followed by slow hydrolysis of methoxy groups. Photochemical degradation occurs upon exposure to UV light (λ > 300 nm) with quantum yield of 0.03 for decomposition.

Acid-Base and Redox Properties

Devapamil functions as a weak base due to its tertiary amine functionality. The conjugate acid exhibits pKa of 8.9 ± 0.1 in water at 25 °C, indicating moderate basicity. Protonation occurs preferentially at the tertiary nitrogen atom, creating a cationic species with increased water solubility.

Redox properties include oxidation potential of +0.85 V vs. SCE for one-electron oxidation of the aromatic system. Reduction potential of -1.25 V vs. SCE corresponds to reduction of the nitrile group. The compound demonstrates stability toward common oxidants including molecular oxygen but undergoes rapid oxidation with strong oxidizing agents like chromium trioxide.

Electrochemical studies reveal reversible one-electron transfer processes with diffusion coefficient of 6.5 × 10⁻⁶ cm²·s⁻¹ in acetonitrile. The compound exhibits antioxidant capacity with ability to scavenge free radicals, particularly through donation of hydrogen atoms from methoxy groups.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The synthesis of devapamil typically proceeds through multi-step organic transformations. The most efficient laboratory route begins with 3,4-dimethoxyphenylacetonitrile, which undergoes alkylation with 1-bromo-2-methylpropane in the presence of sodium hydride in DMF at 0-5 °C. This reaction produces 2-(3,4-dimethoxyphenyl)-2-isopropylacetonitrile with yield of 85% after purification by column chromatography.

The second key intermediate, N-methyl-N-[2-(3-methoxyphenyl)ethyl]amine, prepares through reductive amination of 3-methoxyphenylacetaldehyde with methylamine using sodium cyanoborohydride in methanol. This step achieves yields of 78% with product isolation by distillation under reduced pressure.

Final coupling employs nucleophilic displacement where the bromo derivative of the nitrile intermediate reacts with the secondary amine. The reaction proceeds in acetonitrile with potassium carbonate base at reflux temperature for 12 hours, yielding devapamil after workup and recrystallization from ethanol-water. Overall yield for the three-step sequence typically reaches 62% with chemical purity exceeding 98% by HPLC analysis.

Industrial Production Methods

Industrial-scale production of devapamil utilizes continuous flow chemistry approaches for improved efficiency and safety. The process employs fixed-bed reactors with heterogeneous catalysts for key transformations. Alkylation of 3,4-dimethoxyphenylacetonitrile occurs in a continuous stirred-tank reactor at 10 L·min⁻¹ flow rate with residence time of 45 minutes.

Reductive amination utilizes catalytic hydrogenation with Raney nickel catalyst at 5 atm hydrogen pressure and 80 °C. This continuous hydrogenation process achieves conversion rates exceeding 95% with minimal byproduct formation. The final coupling reaction employs phase-transfer catalysis with aliquat 336 in a continuous flow reactor system operating at 90 °C with residence time of 30 minutes.

Purification integrates continuous chromatography with simulated moving bed technology, achieving purity specifications of >99.5%. Annual production capacity typically ranges from 5-10 metric tons worldwide, with production costs estimated at $1200-1500 per kilogram. Environmental considerations include solvent recovery systems achieving 98% recycling efficiency and treatment of aqueous waste streams through advanced oxidation processes.

Analytical Methods and Characterization

Identification and Quantification

High-performance liquid chromatography represents the primary analytical method for devapamil quantification. Reverse-phase systems utilizing C18 columns (250 × 4.6 mm, 5 μm) with mobile phase comprising acetonitrile:phosphate buffer (pH 3.0) in 65:35 ratio provide optimal separation. Detection occurs at 275 nm with retention time of 7.8 minutes. The method demonstrates linearity (r² > 0.999) over concentration range 0.1-100 μg·mL⁻¹ and limit of detection of 0.03 μg·mL⁻¹.

Gas chromatography-mass spectrometry confirms identity through retention index (Kovats index = 2450) and characteristic mass fragmentation pattern. Capillary electrophoresis with UV detection offers alternative quantification with separation achieved in 15 minutes using 25 mM borate buffer (pH 9.0) with 15 kV applied voltage.

Spectrophotometric methods based on complex formation with bromocresol green enable rapid quantification with detection limit of 0.5 μg·mL⁻¹. Nuclear magnetic resonance spectroscopy provides definitive structural confirmation through comparison of chemical shifts and coupling patterns with authentic standards.

Purity Assessment and Quality Control

Purity assessment typically identifies three principal impurities: N-desmethyl devapamil (0.1-0.3%), devapamil nitrile hydrolysis product (0.2-0.5%), and dimeric condensation products (0.05-0.1%). Specifications require chemical purity ≥98.5% by HPLC area normalization, with individual impurities not exceeding 0.5%.

Residual solvent analysis by gas chromatography limits acetone to <5000 ppm, methanol to <3000 ppm, and DMF to <880 ppm according to ICH guidelines. Heavy metal content must not exceed 20 ppm by atomic absorption spectroscopy. Water content determined by Karl Fischer titration maintains specification of <0.5% w/w.

Stability testing under accelerated conditions (40 °C, 75% relative humidity) shows <2% degradation over 6 months. Photostability testing reveals sensitivity to UV light, requiring protection from light during storage. Shelf life determinations indicate stability for at least 36 months when stored in sealed containers under nitrogen atmosphere at -20 °C.

Applications and Uses

Industrial and Commercial Applications

Devapamil serves primarily as a chemical intermediate in pharmaceutical synthesis, particularly for advanced verapamil analogues and related phenylalkylamine derivatives. Its structural features make it valuable for studying structure-activity relationships in calcium channel modulators. The compound finds application in analytical chemistry as a reference standard for chromatographic methods development and mass spectrometry calibration.

In materials science, devapamil functions as a building block for liquid crystalline compounds due to its rigid aromatic units and flexible alkyl chains. Derivatives exhibit mesomorphic properties with transition temperatures between 85-120 °C. The compound's ability to form stable complexes with metal ions enables applications in extraction chemistry and sensor development.

Commercial demand remains limited to research and development activities, with annual market volume estimated at 50-100 kg worldwide. Production occurs primarily on contract basis for pharmaceutical and chemical research organizations. Cost structure reflects the complex synthesis with market prices ranging from $2000-5000 per gram depending on purity and quantity.

Research Applications and Emerging Uses

Research applications focus on devapamil's utility as a model compound for studying molecular recognition processes. Its conformational flexibility and multiple functional groups make it valuable for host-guest chemistry studies and supramolecular assembly investigations. The compound serves as a template for developing molecularly imprinted polymers with applications in separation science.

Emerging applications include use as a chiral selector in capillary electrophoresis, where devapamil derivatives demonstrate enantioselectivity for various acidic compounds. Research explores its potential as a phase transfer catalyst in asymmetric synthesis due to the presence of both hydrophilic and hydrophobic regions. Recent investigations examine devapamil-based ionic liquids for specialized extraction processes.

Patent literature describes devapamil derivatives as additives for polymer stabilization and as components in electrochemical devices. Ongoing research explores its incorporation into metal-organic frameworks as functional organic linkers, creating materials with tailored porosity and functionality.

Historical Development and Discovery

Devapamil emerged from systematic structure-activity relationship studies conducted in the late 1970s and early 1980s on verapamil analogues. Researchers at Knoll AG first reported the compound in 1983 as part of efforts to develop calcium channel blockers with improved selectivity profiles. Initial synthetic approaches focused on modifying the verapamil structure through methoxy group manipulation and nitrile incorporation.

The 1980s witnessed extensive pharmacological characterization of devapamil and related compounds, establishing their effects on calcium flux in various tissue preparations. During this period, researchers developed improved synthetic routes that enabled larger-scale production for detailed physicochemical studies. The 1990s brought advanced analytical methods that permitted thorough characterization of devapamil's stereochemistry and conformational properties.

Recent decades have seen renewed interest in devapamil as a scaffold for developing new functional materials and as a model compound for studying molecular interactions. Advances in asymmetric synthesis have enabled production of enantiomerically pure forms, facilitating detailed structure-property relationship studies. Current research continues to explore novel applications in materials science and analytical chemistry.

Conclusion

Devapamil represents a structurally complex phenylalkylamine derivative with significant scientific interest despite limited commercial applications. Its combination of aromatic methoxy groups, tertiary amine functionality, and nitrile group creates a molecule with distinctive electronic properties and conformational behavior. The compound serves as an important model for studying structure-activity relationships in medicinal chemistry and molecular recognition processes in supramolecular chemistry.

Future research directions include development of more efficient asymmetric synthesis methods, exploration of devapamil-based materials with tailored properties, and investigation of its potential as a chiral auxiliary or catalyst in organic synthesis. The compound's unique combination of flexibility and functionality continues to make it valuable for fundamental studies of molecular interactions and for developing new chemical technologies.